Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

My thinking is the ascite fluid build up and speen tumors were brought on by the primary ovarian cancer. The secondary affects responding to Kevetrin after only 3 courses. I thought this trial was reserved for patients that have no other course of action left, if so where did she go or was she well enough after the Kevetrin treatments to again seek a more direct approved ovarian treatment. Just a thought.